COMBINATIONAL EFFECTS OF ETHYLACETATE EXTRACT OF PICRIA FEL-TERRAE LOUR AND DOXORUBICIN ON T47D BREAST CANCER CELLS

Authors

  • Denny Satria Department of Pharmaceutical Biology, 2Department of Pharmacology
  • Mainal Furqan University of Sumatera Utara
  • Sumadio Hadisahputra University of Sumatera Utara
  • Rosidah . University of Sumatera Utara

Keywords:

Combination, Picria fel-terrae Lour, T47D, doxorubicin

Abstract

Objective: To evaluate the effects of ethyl acetate extract (EAE) of Picria fel-terrae Lour. Leaves and combination with doxorubicin on cytotoxicity, cell cycle, apoptotis and suppression of cyclin D1 and Bcl-2 expression on T47D cell lines.

Methods: The in vitro cytotoxicity effects were determined using MTT assay. Analysis of cell cycle distribution was performed using flow cytometer and the data was analyzed using ModFit LT 3.0 program. Apoptotis assay was analyzed using flow cytometer using Annexin V. The suppression of cyclin D1 and Bcl-2 expression on T47D cell lines was identified using immune cytochemistry.

Results: Cytotoxicity activity and combination of EAE with doxorubicin were evaluated using the MTT assay. The combination represents higher inhibitory effect on cell growth than the single treatment of doxorubicin on T47D cell lines. The combination changes the accumulation of cell cycle phase from G0-G1. The combination also increases apoptosis. The combination also showed suppression of cyclin D1 and Bcl-2 expression in T47D cell lines.

Conclusion: Based on the results, EAE is potential to be developed as co-chemotherapeutic for breast cancer by inducing apoptosis, cell cycle arrest and suppressing cyclin D1 and Bcl-2 expression. However, the molecular mechanism needs to be explored further. 

 

Downloads

Download data is not yet available.

References

Wasita H. Obat tradisional kekayaan indonesia. Yogyakarta: Graha Ilmu; 2011. p. 2-4.

Mikail CN, Hearney E, Nemesure B. Increasing physician awareness of the common uses and contraindications of herbal medicines: utility of a case-based tutorial for residents. J Alternative Complementary Med 2003;9(4):571-6.

Nugroho AE, Adam H, Dyaningtyas DPP, Anindya N, Edy M. Combinational effects of hexane insoluble fraction of Ficus septicaBurm. F. and doxorubicin chemotherapy on T47D breast cancer cells. Asian Pac J Trop Biomed 2013;3(4):297-302.

Zhong SQ, Zhang BN, Huang FX. An anti-tumor herb Cucao. China: China Traditionally Herb Drugs Lett; 1979. p. 45-6.

Jemal A, Rebecca S, Xu J, Elizabeth W. Cancer statistics 2010. CA Cancer J Clin 2010;60:277-300.

Lestari P. Efek kombinasi ekstrak aktif daun poguntano (Picria fel-terrae Lour.) dengan doksorubisin terhadap sel kanker payudara secara In vitro. Thesis: Medan. Faculty of Pharmacy. University of Sumatera Utara; 2013.

Ueda J, Tezuka Y, Banskota AH, Tran QK, Harimaya Y, Saiki, I, et al. Antiproliferatif acting of Viatnemesce medical plants. Biol Pharm Bull 2002;25(6):753-60.

Mosmann T. Rapid colorimetric assay forn cellular growth and survival: aplication to proliferation and citotoxicity assays. J Immunol Methods 1983;65:55-63.

Prayong P, Barusrux S, Weerapreeyakul N. Cytotoxic activity screening of some indigenous Thai plants. Fitoterapia 2008;79:598-601.

Hostanka K, Nisslein T, Freudenstein J, Reichling J, Saller R. Evaluation of cell death caused by triterpene glycosides and phenolic substances from Cimifigua racemosa extract in human MCF-7 breast cancer cells. Biol Pharm 2004;27(12):1970-5.

Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, et al. Synergistic effect of ERK inhibition on tetrandine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci 2009;10(1):23-8.

Yadav VR, Sahdeo P, Bokyung S, Ramaswamy K, Bharat BA. Targetting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins 2010;2:2428-66.

Machana S, Natthida W, Sahapat B, Bungorn S, Thaweesak T. Cytotoxic and apoptotic effects of six herbal plants against the human hepatocarcinoma (HepG2) cell line. Chin Med 2011;6:39.

Di Leo A, Tanner M, Desmed C, Paesman M, Cardoso F, Durbecq V, et al. p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial. Annu Oncol 2007;18:997-1003.

Vayssade M, Haddada H, Faridoni-laurens L, Tourpin S, Valent A, Benard J, et al. p73 fuctionally replaces p53 in adriamycin-treated, p53-deficient breast cancer cells. Int J Cancer 2005;116(6):860-9.

Rudin CM, Thompson CB. Regulation and clinical relevance of programmed cell death. Annu Rev Med 1997;48:267-81.

Ricci MS, Zhong WX. Chemoterapeutic approaches for targeting cell death pathways. Oncologist 2006;11:342-57.

Budityastomo H. Pemberian fraksi etanolik ekstrak bawang dayak terhadap tingkat ekspresi cyclin-E galur sel kanker serviks uteri HeLa. Thesis: Surakarta. Fakultas Kedokteran Universitas Sebelas Maret; 2010. p. 58.

Kumar V, Abas AK, Foustro N. Pathology basic of disease. New York: Elsevier Inc; 2005. p. 270-336.

Foster JS, Henley DC, Ahamed S, Wimalasena J. Estrogen and cell regulation in breast cancer. Trends Endocrinol Metab 2001;12(7):320-7.

King RJB. Biology of Cancer 2nd edition. London; Pearson Education Limited; 2000. p. 157-65.

Published

01-07-2015

How to Cite

Satria, D., M. Furqan, S. Hadisahputra, and R. . “COMBINATIONAL EFFECTS OF ETHYLACETATE EXTRACT OF PICRIA FEL-TERRAE LOUR AND DOXORUBICIN ON T47D BREAST CANCER CELLS”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 7, July 2015, pp. 73-76, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/4304.

Issue

Section

Original Article(s)